A once-daily oral peptide improved ulcerative colitis response and remission rates in a phase 2 trial, offering a potential ...

A retrospective cohort study found that prior anti-TNF exposure was associated with a statistically significant reduction in ...

Takeda (TSE:4502/NYSE:TAK) announced new data from VERDICT (NCT04259138), showing that treating adults with intravenous ENTYVIO ® (vedolizumab) to achieve corticosteroid-free (CSF) disease clearance ...

A class of blood pressure medications may improve a widely used treatment for ulcerative colitis, the most common type of inflammatory bowel disease, suggests a new study, led by Northwestern Medicine ...

Can Surgery Cure Ulcerative Colitis? Alan Moss, MD, chief scientific officer of the Crohns & Colitis Foundation, clearly explains the surgeries available to people with ulcerative colitis, and their ...

A large-scale retrospective cohort study found that patients with ulcerative colitis and obesity faced significantly higher ...

Ulcerative colitis can cause symptoms like bloody stool, diarrhea, and fatigue. Family history, age, and ethnicity are factors that can affect risk.

One-year results from SHINE-2 in children and adolescents with ulcerative colitis Of the patients enrolled in SHINE-2, 81% achieved clinical response at Week 12. Among responders, ages 6 to 17, ...

Chaudhry N, et al. Real-world comparative effectiveness of TNF inhibitors, vedolizumab, and JAK inhibitors in ulcerative colitis: A propensity score-weighted analysis. Presented at: ACG Annual ...

Add Yahoo as a preferred source to see more of our stories on Google. "Debilitating digestive issues dominated my life because I couldn't go longer than a half hour without going to the bathroom," ...

Can Surgery Cure Ulcerative Colitis? Alan Moss, MD, chief scientific officer of the Crohns & Colitis Foundation and director of the Crohn's and colitis program at Boston Medical Center, clearly ...